For the year ending 2025-12-31, AORT had $11,445K increase in cash & cash equivalents over the period. $839K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | 9,768 |
| Depreciation and amortization | 22,458 |
| Non-cash compensation | 24,385 |
| Non-cash lease expense | 5,170 |
| Write-down of inventories and deferred preservation costs | 4,900 |
| Non-cash interest expense | 1,705 |
| Deferred income taxes | 37 |
| Change in fair value of contingent consideration | 7,700 |
| Endospan fair value adjustments | -2,337 |
| Losses on inducement/extinguishment of debt | -2,664 |
| Gain from sale of non-financial assets | 7,000 |
| Other | -7,409 |
| Receivables | 7,269 |
| Inventories and deferred preservation costs | 15,277 |
| Prepaid expenses and other assets | 1,798 |
| Accounts payable, accrued expenses, and other liabilities | 2,183 |
| Net cash flows provided by operating activities | 39,880 |
| Capital expenditures | 39,041 |
| Payments under endospan agreements | 8,000 |
| Proceeds from sale of non-financial assets, net | 5,000 |
| Net cash flows used in investing activities | -42,041 |
| Proceeds from issuance of long-term debt | 0 |
| Proceeds from revolving credit facility | 0 |
| Repayment of debt | 210 |
| Proceeds from exercise of stock options and issuance of common stock | 13,074 |
| Payment of debt issuance costs | 1,750 |
| Proceeds from financing insurance premiums | 3,117 |
| Principal payments on short-term notes payable | 2,250 |
| Redemption and repurchase of stock to cover tax withholdings | 0 |
| Other | -699 |
| Net cash flows provided by financing activities | 11,282 |
| Effect of exchange rate changes on cash and cash equivalents | 2,324 |
| Increase (decrease) in cash and cash equivalents | 11,445 |
| Cash and cash equivalents at beginning of period | 53,463 |
| Cash and cash equivalents at end of period | 64,908 |
ARTIVION, INC. (AORT)
ARTIVION, INC. (AORT)